In the area of liver fibrosis research, Bangen and colleagues demonstrated that inhibiting the cell cycle protein cyclin E1 during liver fibrosis progression in CCl4-induced fibrosis significantly reduced disease severity [203]. This evidence concerns the gene CCNE1 and Hepatic fibrosis.